Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage
Completed · Phase 1
Conditions studied: Hemorrhagic Stroke, Intracerebral Hemorrhage
In brief
The overall goal of this study is to develop mesenchymal stem cell therapy for treatment of acute spontaneous hemorrhagic stroke.
Key facts
- Study ID
- NCT03371329
- Run by
- Mayo Clinic
- People needed
- 9
- Starts
- 2017-12-12
- Expected to finish
- 2020-10-09
- Last updated by the study team
- 2020-12-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic in Florida — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.